|
LEXX | Lexaria Bioscience Corp. |
|
|
LEXX | Lexaria Bioscience Corp. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.58 |
| Leverage | 23.36% |
| Market Cap | $ 8.9m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -11.4m |
| Margin | -1862.64% |
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.